Radiofrequency Ablation of Metastatic Pheochromocytoma

Journal of Vascular and Interventional Radiology

Volumn 20, Issue 11, 2009, Pages 1483-1490

  Venkatesan, Aradhana M ^a   Locklin, Julia ^a   Lai, Edwin W ^b   Adams, Karen T ^b   Fojo, Antonio Tito ^c   Pacak, Karel ^b   Wood, Bradford J ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ADULT; AGED; ARTICLE; CATECHOLAMINE SYNTHESIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; METASTASIS; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; TUMOR NECROSIS;

ADRENAL GLAND NEOPLASMS; ADULT; AGED; BONE NEOPLASMS; CATHETER ABLATION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PHEOCHROMOCYTOMA; TREATMENT OUTCOME;

EID: 70350475570     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2009.07.031     Document Type: Article

References (22)

1. Lenders J.M., Eisenhofer G., Mannelli M., and Pacak K. Phaeochromocytoma. Lancet 366 (2005) 665-675
2. Reisch N., Peczkowska M., Januszewicz A., and Neumann H.H. Pheochromocytoma: presentation, diagnosis and treatment. J Hypertens 24 (2006) 2331-2339
3. Mantero F., Terzolo M., Arnaldi G., et al. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85 (2000) 637-644
4. Scholz T., Eisenhofer G., Pacak K., Drall H., and Lehnert H. Current treatment of malignant pheochromocytoma. J Clin Endocrinol Metab 92 (2007) 1217-1225
5. Schlumberger M., Gicquel C., Lumbroso J., et al. Malignant pheochromocytoma: clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases. J Endocrinol Invest 15 (1992) 631-642
6. O'Riordain D.S., Young Jr. W.F., Grant C.S., Carney J.A., and van Heerden J.A. Clinical spectrum and outcome of functional extra-adrenal paraganglioma. World J Surg 20 (1996) 916-921
7. Eisenhofer G., Bornstein S.R., Brouwers F.M., et al. Malignant pheochromocytoma: current status and initiatives for future progress. Endocr Relat Cancer 11 (2004) 423-436
8. John H., Ziegler W.H., Hauri D., and Jaeger P. Pheochromocytomas: can malignant potential be predicted?. Urology 53 (1999) 679-683
9. Goldstein R.E., O'Neill J.A., Holcomb G.W., et al. Clinical experience over 48 years with pheochromocytoma. Ann Surg 229 (1999) 755-764
10. Rhim H., Goldberg S.N., Dodd G.D., et al. Essential techniques for successful radiofrequency thermal ablation of malignant hepatic tumors. Radiographics 21 Suppl (2001) S17-S39
11. Rosenthal D.I., Hornicek F.J., Wolfe M.W., Jennings L.C., Gebhardt M.C., and Mankin H.J. Percutaneous radiofrequency coagulation of osteoid osteoma compared with operative treatment. J Bone Joint Surg 80 (1998) 815-821
12. Sacks D., McClenny J., Cardella J., and Lewis C. Society of Interventional Radiology Clinical Practice Guidelines. J Vasc Interv Radiol 14 Suppl (2003) S199-S202
13. Eisenhofer G., Goldstein D.S., Stull R., et al. Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem 32 (1986) 2030-2033
14. Lo W.K., VanSonnenberg E., and Shankar S. Percutaneous CT-guided radiofrequency ablation of symptomatic bilateral adrenal metastases in a single session. J Vasc Interv Radiol 17 (2006) 175-179
15. Wood B.J., Abraham J., Hvizda J.L., Alexander H.R., and Fojo T. Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases. Cancer 97 (2003) 554-560
16. Mayo-Smith W.W., and Dupuy D.E. Adrenal neoplasms: CT-guided radiofrequency ablation-preliminary results. Radiology 231 (2004) 225-230
17. Onik G., Onik C., Medary I., et al. Life-threatening hypertensive crises in two patients undergoing hepatic radiofrequency ablation. AJR Am J Roentgenol 181 (2003) 495-497
18. Chini E.N., Brown M.J., Farrell M.A., and Charboneau W. Hypertensive crisis in a patient undergoing percutaneous radiofrequency ablation of an adrenal mass under general anesthesia. Anesth Analg 99 (2004) 1867-1869
19. Mamlouk M.D., vanSonnenberg E., Stringfellow G., Smith D., and Wendt A. Radiofrequency ablation and biopsy of metastatic pheochromocytoma: emphasizing safety issues and dangers. J Vasc Interv Radiol 20 (2009) 670-673
20. Eisenhofer G., Rivers G., Rosas A.L., Quezado Z., Manger W.M., and Pacak K. Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management. Drug Saf 30 (2007) 1031-1062
21. Perry R.R., Keiser H.R., Norton J.A., Wall R.T., Robertson C.N., and Travis W. Surgical management of pheochromocytoma with the use of metyrosine. Ann Surg 212 (1990) 621-628
22. Steinsapir J., Carr A.A., Prisant M., and Bransome E.D. Metyrosine and pheochromocytoma. Arch Intern Med 157 (1997) 901-906